M&A

What price for Big Pharma M&A in the supplements business?

Drugmakers are turning to vitamins for a shot of consumer health growth, and a host of supplement makers are prime targets. But with consumer product companies vying for the same buyouts, prices could be steep. Report

Merck KGaA, not Pfizer, lands consumer health deal with P&G

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

by Carly Helfand Apr 19, 2018 9:25am

M&A

Sanofi confirms plans to hand Zentiva off to Advent

Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."

by Eric Sagonowsky Apr 17, 2018 10:12am

Pharma

With Takeda still eyeing a buy, Shire casts off oncology for $2.4B

With suitor Takeda circling Shire, the Dublin-based target has pulled off a deal of its own.

by Carly Helfand Apr 16, 2018 12:05pm

M&A

What price for Big Pharma M&A in the supplements business?

Suggested Articles

Merck KGaA, not Pfizer, lands consumer health deal with P&G

Sanofi confirms plans to hand Zentiva off to Advent

With Takeda still eyeing a buy, Shire casts off oncology for $2.4B